Related content

The Influenza Pandemic of 2009: Lessons and Implications

By Shapshak Paul   Chiappelli Francesco   Somboonwit Charurut   Sinnott John  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 2, 2011-04 ,pp. : 63-81

Adis International

Access to resources Recommend Favorite

The clinical effectiveness of oseltamivir in mild cases of pandemic influenza A H1N1 2009 infection

By Lee Jin Seo   Park So Yeon   Kim Jae Seok   You Ji Young   Ju Young-Su   Eom Joong Sik  

Scandinavian Journal of Infectious Diseases, Vol. 44, Iss. 8, 2012-08 ,pp. : 595-599

Informa Healthcare

Access to resources Recommend Favorite

Evaluating the Impact of Pharmacies on Pandemic Influenza Vaccine Administration

By  

Disaster Medicine and Public Health Preparedness, Vol. 11, Iss. 5, 2017-02 ,pp. : 587-593

Cambridge University Press

Access to resources Recommend Favorite

Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 2, 2014-02 ,pp. : 197-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007–2008 and 2008–2009 seasons

By Kawai Naoki   Ikematsu Hideyuki   Tanaka Osame   Matsuura Shinro   Maeda Tetsunari   Yamauchi Satoshi   Hirotsu Nobuo   Nishimura Mika   Iwaki Norio   Kashiwagi Seizaburo  

Journal of Infection and Chemotherapy, Vol. 17, Iss. 3, 2011-06 ,pp. : 375-381

Springer Publishing Company

Access to resources Recommend Favorite